Question: Activating mutations in a raf gene are common in driving the formation and maintenance of human m…
Show transcribed image text Activating mutations in a raf gene are common in driving the formation and maintenance of human melanoma s. Drugs that target this hyperactive raf protein are tnltlalty effective m combaVmgtVus cancer. However, in some cases, additional activating mutations in the raf gene occur and the melanoma cells become resistant to the first drug. Two companies are synthesizing secondary drugs to combat this resistant melanoma. Company A, has produced a drug that inhibits ras activity, whereas Company B has produced a MEK inhibitor. Shoul you buy stock in Company A or Company B (i.e. which company is likely to have an effective drug for the resistant melanoma) Explain Your choice.
Activating mutations in a raf gene are common in driving the formation and maintenance of human melanoma s. Drugs that target this hyperactive raf protein are tnltlalty effective m combaVmgtVus cancer. However, in some cases, additional activating mutations in the raf gene occur and the melanoma cells become resistant to the first drug. Two companies are synthesizing secondary drugs to combat this resistant melanoma. Company A, has produced a drug that inhibits ras activity, whereas Company B has produced a MEK inhibitor. Shoul you buy stock in Company A or Company B (i.e. which company is likely to have an effective drug for the resistant melanoma) Explain Your choice.
